These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38678256)

  • 1. Implementation opportunities and challenges to piloting a community-based drug-checking intervention for sexual and gender minority men in Vancouver, Canada: a qualitative study.
    Coulaud PJ; Chayama KL; Schwartz C; Purdie A; Lysyshyn M; Ti L; Knight R
    Harm Reduct J; 2024 Apr; 21(1):87. PubMed ID: 38678256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of integrating mental health and substance use care within sexual health services among young sexual and gender minority men in Vancouver, Canada.
    Coulaud PJ; Parent N; Stehr R; Salway T; Knight R
    Int J Drug Policy; 2024 Jun; 128():104459. PubMed ID: 38788388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis.
    Goodyear T; Mniszak C; Jenkins E; Fast D; Knight R
    Harm Reduct J; 2020 Mar; 17(1):23. PubMed ID: 32228646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M; Foreman-Mackey A; Ivsins A; Bardwell G
    Harm Reduct J; 2023 Apr; 20(1):61. PubMed ID: 37118799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Sexual and Gender Minority Cancer Care: Patient and Caregiver Perspectives From a Multi-Methods Pilot Study.
    Kano M; Jaffe SA; Rieder S; Kosich M; Guest DD; Burgess E; Hurwitz A; Pankratz VS; Rutledge TL; Dayao Z; Myaskovsky L
    Front Oncol; 2022; 12():833195. PubMed ID: 35600396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
    Moran L; Ondocsin J; Outram S; Ciccarone D; Werb D; Holm N; Arnold EA
    Harm Reduct J; 2024 May; 21(1):92. PubMed ID: 38734643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19.
    Carroll JJ; Mackin S; Schmidt C; McKenzie M; Green TC
    Harm Reduct J; 2022 Feb; 19(1):9. PubMed ID: 35120531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B; van Roode T; Pagan F; Hore D; Pauly B
    BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
    Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "It's probably an STI because you're gay": a qualitative study of diagnostic error experiences in sexual and gender minority individuals.
    Wiegand AA; Sheikh T; Zannath F; Trudeau NM; Dukhanin V; McDonald KM
    BMJ Qual Saf; 2024 Jun; 33(7):432-441. PubMed ID: 37164638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis use and mental health among young sexual and gender minority men: A qualitative study.
    Parent N; Coulaud PJ; Amirie M; Ferlatte O; Knight R
    Int J Drug Policy; 2021 May; 91():102980. PubMed ID: 33051088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental Health Challenges and Needs among Sexual and Gender Minority People in Western Kenya.
    Harper GW; Crawford J; Lewis K; Mwochi CR; Johnson G; Okoth C; Jadwin-Cakmak L; Onyango DP; Kumar M; Wilson BDM
    Int J Environ Res Public Health; 2021 Feb; 18(3):. PubMed ID: 33535647
    [No Abstract]   [Full Text] [Related]  

  • 16. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
    Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
    Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Impacting Implementation of Evidence-Based Strategies to Create Safe and Supportive Schools for Sexual and Gender Minority Students.
    Green AE; Willging CE; Ramos MM; Shattuck D; Gunderson L
    J Adolesc Health; 2018 Nov; 63(5):643-648. PubMed ID: 30205932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.